Abstract
Pure primary ovarian squamous cell carcinoma (SCC) is a rare lesion that usually arises from the malignant transformation of an existing ovarian dermoid cyst. The de novo occurrence of an ovarian SCC in the absence of a prior ovarian dermoid cyst, Brenner tumor or endometriosis is extremely rare. At present, no effective therapy exists for treating pure primary ovarian SCC. The present case study describes a patient that presented with progressive coughing, who was diagnosed with an International Federation of Gynecology and Obstetrics stage IV pure primary ovarian SCC with lung metastases. The patient received postoperative chemotherapy, however, the patient succumbed to the disease. The current study also presents a review of the literature.
Highlights
The incidence of a pure primary ovarian squamous cell carcinoma (SCC) is extremely rare when not associated with pre‐existing ovarian lesions, such as dermoid cysts, Brenner tumors or endometriosis [1]
The present case study describes a patient with pure primary ovarian SCC, and presents a review of the literature
The patient was subsequently diagnosed with stage IVB pure primary ovarian SCC with lung metastases according to the International Federation of Gynecology and Obstetrics staging system [2]
Summary
The incidence of a pure primary ovarian squamous cell carcinoma (SCC) is extremely rare when not associated with pre‐existing ovarian lesions, such as dermoid cysts, Brenner tumors or endometriosis (whose presence is normally indicative of ovarian SCC) [1]. Due to the rarity of pure primary ovarian SCC, the clinical features of the disease have not been established and effective treatments are yet to be identified. Subsequent to optimal tumor devulking, patients with early‐stage pure primary ovarian SCC may remain disease‐free. Those patients with advanced‐stage disease may experience a poorer outcome, despite treatment with postoperative chemotherapy and/or radiotherapy. The patient was subsequently diagnosed with stage IVB pure primary ovarian SCC with lung metastases according to the International Federation of Gynecology and Obstetrics staging system [2]. To identify effective therapies for the treatment of pure primary ovarian SCC, further clinical investigations are required
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
